
AOD-9604 Nasal Spray
15ml · 99%+ Purity
Description
AOD-9604 nasal spray 15ml at 99%+ purity. Convenient daily delivery for fat metabolism and weight loss research.
Disclaimer: The images on this page are for illustrative purposes only. Peptodio is an educational resource and does not sell any products, nor will we ever. We do not recommend or endorse any sellers or vendors. This information is provided for research and educational purposes only.
Research & Science
Evidence-based information about this compound
Chemical Properties
Molecular Formula
C78H123N23O23S2
Molecular Weight
1815.1 g/mol
Amino Acid Sequence
Tyr-Leu-Arg-Ile-Val-Gln-Cys-Arg-Ser-Val-Glu-Gly-Ser-Cys-Gly-Phe
Also known as:
AOD 9604, Anti-Obesity Drug 9604, HGH Fragment 176-191
AOD-9604 Nasal Spray delivers the same modified fragment of human growth hormone through a convenient intranasal route. This formulation provides an alternative delivery method that offers rapid absorption without the need for injection.
The nasal mucosa provides a highly vascularized absorption surface with direct access to systemic circulation. Each spray delivers a precise, measured dose, making administration simple and consistent.
AOD-9604 represents amino acids 176-191 of the HGH molecule, the region identified as responsible for fat metabolism effects, modified with a tyrosine at the N-terminus for enhanced stability.
Intranasal AOD-9604 works through the same mechanisms as injectable forms:
- Lipolytic Activity: Stimulates lipolysis (fat breakdown) through beta-3 adrenergic receptor pathways.
- Lipogenesis Inhibition: Prevents new fat cell formation by blocking lipogenic enzymes.
- Metabolic Effects: Influences fat metabolism without affecting IGF-1 or blood glucose levels.
- Rapid Absorption: Nasal delivery provides quick absorption into systemic circulation.
AOD-9604 has been studied extensively for its fat metabolism effects:
- Lipolysis: Stimulates fat breakdown in adipose tissue.
- Lipogenesis: Reduces new fat formation.
- Metabolic Safety: Does not affect IGF-1, insulin, or glucose levels.
- Clinical Studies: Has undergone Phase 2 clinical trials for obesity.
These properties make AOD-9604 valuable for metabolism research.
Sources:
This information is provided for educational purposes only and is based on published scientific research. This product is intended for research use only.



